We have recently shown that the hormonal form of vitamin D 3 , 1,25(OH) 2 -vitamin D 3 (1,25(OH) 2 D 3 ), stimulates the enzymatic activity of the non-receptor protein tyrosine kinase c-Src in skeletal muscle cells. In this study we show that intracellular and extracellular Ca 2 chelation with BAPTA and EGTA, respectively, blocked hormone stimulation of c-Src activity/dephosphorylation, indicating that the calcium messenger system is an upstream activator of c-Src. Tyrosine phosphorylation and stimulation of the growth-related mitogen-activated protein kinase (MAPK) by 1,25(OH) 2 D 3 was shown to be dependent on activation of c-Src, since pretreatment with the c-Src specific inhibitor PP1 or muscle cell transfection with an antisense oligodeoxynucleotide directed against c-Src mRNA markedly reduced hormone stimulation of MAPK phosphorylation. Evidence was obtained indicating that MAPK is then translocated to the cell nucleus in active phosphorylated form and induces the expression of c-myc oncoprotein, as the MAPK kinase (MEK) inhibitor PD98059 abolished stimulation of c-myc synthesis by 1,25(OH) 2 D 3 . In addition, the hormone rapidly stimulated tyrosine phosphorylation of c-myc. In cells pretreated with PP1 (4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo-D3,4-pyrimidine), the 1,25(OH) 2 D 3 -induced increase in tyrosine phosphorylation of c-myc was suppressed. Taken together, these results demonstrate that 1,25(OH) 2 D 3 stimulates proliferation-associated signalling pathways in skeletal muscle cells and implicate c-Src kinase as mediator of this response. ß
Introduction
1,25-Dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ), the major biologically active metabolite of vitamin D 3 , has a well-recognized role in the regulation of mineral metabolism [1, 2] and also in£uences cellular proliferation and di¡erentiation [3, 4] . As for sex steroid hormones it was thought that all the e¡ects of 1,25(OH) 2 D 3 were mediated by binding to a nuclear receptor (vitamin D receptor; VDR) [5] which in turn interacts with speci¢c response elements of a wide number of genes [6] . However, 1,25(OH) 2 D 3 also exerts rapid actions (seconds to minutes) on the plasma membrane, activating several signalling cascades, an observation which was initially reported for the duodenum [7] and promptly extended to several other classical as well as non-classical target tissues [8^13] . The initiation of the fast 1,25(OH) 2 D 3 signal may involve binding to a novel membrane receptor, whose existence received ¢rst experimental support in enterocytes [14] and more recently in chondrocytes [15] . Diverse transmembrane signalling systems mediate the non-genomic actions of 1,25(OH) 2 D 3 in muscle cells, resulting in G protein-mediated modulation of adenylyl cyclase and phospholipases C, D and A 2 and activation of protein kinases A (PKA) and C (PKC), which in turn regulate the activity of voltage-dependent Ca 2 channels (VDCC) [16^21] . In addition, the hormone promotes Ca 2 mobilization from intracellular stores and modulates the Ca 2 release-activated Ca 2 in£ux (SOC) pathway as part of the 1,25(OH) 2 D 3 -induced Ca 2 entry across the plasma membrane of skeletal muscle cells [22, 23] . Recent evidence indicates that 1,25(OH) 2 D 3 rapidly stimulates the enzymatic activity of c-Src tyrosine kinase in embryonic skeletal muscle cells [24] , rat colonocytes [25] and human keratinocytes [26] . In intestinal and skin cells the hormone induces c-Src-mediated tyrosine phosphorylation of PLCQ and the adaptor protein Shc, respectively [23] . Non-receptor tyrosine kinases are believed to act as signal transduction molecules which link up the signals originating from receptors with appropriate downstream e¡ector pathways, such as the mitogen-activated protein (MAP) kinase (MAPK) pathway [27, 28] . Congruent with this concept, it has been shown that 1,25(OH) 2 D 3 is able to stimulate the MAP kinase signalling cascade in promyelocytic NB4 leukaemia cells [29] , chick enterocytes [30] and skeletal muscle cells [31] as evidenced by hormone-dependent increases in tyrosine phosphorylation and enzymatic activity of MAPK.
The signi¢cance of non-genomic signalling through c-Src stimulation is largely unknown. There is some evidence that tyrosine phosphorylation events initiated by c-Src activation may play an important role in the modulation of cellular growth by 1,25(OH) 2 D 3 [31, 32] . In view of the mitogenic role of 1,25(OH) 2 D 3 in embryonic skeletal muscle cells [33^35] , in the present study we have investigated whether c-Src is required for 1,25(OH) 2 -vitamin D 3 signalling to the nucleus in these cells.
Material and methods

Chemicals
1,25(OH) 2 D 3 was supplied by Dr. Heinrich Bachmann (Ho¡mann-La Roche, Basel, Switzerland). Myelin basic protein, enolase, compound PD98059, protein A-Sepharose, Dulbecco's modi¢ed Eagle's medium (DMEM) and fetal bovine serum were from Sigma (St. Louis, MO, USA). Lipofectin was from Gibco BRL (Gaithersburg, MD, USA). Rabbit polyclonal anti-phosphotyrosine antibody was obtained from Upstate Biotechnology (Lake Placid, NY, USA). Anti-active MAP kinase antibody (reactive against p42 and p44 isoforms) and anti-Src antibody were from Promega (Madison, WI, USA). Anti-c-myc antibody was purchased from Oncogene Research Products (Cambridge, MA, USA). Secondary antibody goat anti-rabbit horse radish peroxidase-conjugated IgG and the Super Signal CL-HRP substrate system for enhanced chemiluminescence (ECL) were obtained from Amersham (Arlington Heights, IL, USA). [Q-
32 P]ATP (3000 Ci/mmol) was from New England Nuclear (Chicago, IL, USA). Sense and antisense oligodeoxynucleotides were synthesized by the DNAgency (Malvern, PA, USA). All other reagents were of analytical grade.
Cell culture
Chick skeletal muscle cells (myoblasts) were obtained from 13-day-old chick embryo breast muscles by stirring in Earl's balanced salt solution (SSBE) containing 0.1% trypsin during 30 min essentially as previously described [36] . The freed cells were collected by centrifugation and the pellet was resuspended in DMEM supplemented with 10% fetal bovine serum and antibiotic^antimycotic solution. The suspension was dispersed by pipetting, ¢ltered through nylon mesh and preplated on gelatin-coated petri dishes to remove contaminating ¢broblasts. The unadsorbed cells were seeded at an appropriate density (120 000 cells/cm 2 ) in petri dishes (80 mm diameter) and cultured at 37³C under a humidi¢ed atmosphere (air/5% CO 2 ). Cells were allowed to grow until con£uence (4^5 days after plating) before use. Under these conditions, myoblasts proliferate within the ¢rst 48 h and at day 4 become di¡erentiated into myotubes expressing both biochemical and morphological characteristics of adult skeletal muscle ¢bres [37] .
Isolation of cell nuclei
Cells were resuspended in 10 mM Tris^HCl pH 7.4, 1.6 M sucrose, 0.1 mM Na 3 VO 4 , 5 mM DTT and 0.3 mM phenylmethylsulphonyl £uoride (PMSF) and then sonicated for 15 s. The nuclei were obtained by layering the lysed cell suspension on a sucrose cushion (2 M) and subjecting the samples to centrifugation at 4000Ug at 4³C, for 15 min. The nuclear pellets were washed twice in lysis bu¡er. Microscopic examination of the pellet after trypan blue staining revealed a high yield of puri¢ed nuclei. Nuclei were immediately frozen and stored at 370³C until used in the assays. Measurement of cytosolic glucose-6-phosphate dehydrogenase in the nuclear and supernatant fractions [38] showed no detectable enzymatic activity associated to the nuclei (data not shown).
Immunoprecipitation
After treatment, muscle cells were lysed (30 min at 4³C) in 50 mM Tris^HCl, pH 7.4, 150 mM NaCl, 2 mM EGTA, 25 mM NaF, 0.2 mM sodium orthovanadate, 1 mM PMSF, 2 Wg/ml leupeptin, 2 Wg/ml pepstatin, 2 Wg/ml aprotinin, 0.25% sodium deoxycholate and 1% NP40. Insoluble material was pelleted in a microcentrifuge at 14 000 rpm for 10 min. The protein content of the clear lysates was determined according to Lowry [39] . Aliquots (5007 00 Wg protein) were incubated overnight at 4³C with anti-Src or anti-c-myc antibodies, followed by precipitation of the complexes with protein A conjugated with Sepharose. The immune complexes were washed ¢ve times with cold immunoprecipitation bu¡er (10 mM Tris^HCl, pH 7.4, 150 mM NaCl, 1 mM EGTA, 1 mM EDTA, 0.2 mM PMSF, 0.2 mM sodium orthovanadate, 1% Triton X-100 and 1% NP40).
SDS^PAGE and immunoblotting
Immunoprecipitated proteins (or lysate proteins) dissolved in Laemmli sample bu¡er were separated on SDS^polyacrylamide (8%) gels [40] , and electrotransferred to polyvinylidene di£uoride (PVDF) membranes. The membranes were blocked for 1 h at room temperature in TBST (50 mM Tris^HCl, pH 7.4, 200 mM NaCl, 1% Tween 20) containing 1% dry milk. For the detection of proteins, membranes were subjected to immunoblotting using a rabbit anti-phosphotyrosine, anti-active MAP kinase (p42 and p44 isoforms) or anti c-myc antibodies.
Next, the membranes were washed three times in TBST, incubated with a 1/10 000 dilution of peroxidase-conjugated anti-rabbit secondary antibody for 1 h at room temperature and washed three additional times with TBST. The membranes were then visualized using an enhanced chemiluminescent technique (ECL, Amersham), according to the manufacturer's instructions. Images were obtained with a model GS-700 Imaging Densitometer from Bio-Rad (Hercules, CA, USA) by scanning at 600 dpi and printing at the same resolution. Bands were quanti¢ed using the Molecular Analyst program (Bio-Rad).
Measurement of Src kinase activity
Cell lysates were prepared followed by immunoprecipitation of Src as described above. After three washes with immunoprecipitation bu¡er and two washes with kinase bu¡er (50 mM Tris^HCl, pH 7.4, 5 mM MgCl 2 , 1 mM dithiothreitol, 0.1 mM sodium orthovanadate), the immune complexes were incubated at 30³C for 10 min in kinase bu¡er (30 Wl/sample) containing enolase as an exogenous substrate for Src (2.5 Wg/assay), 50 WM ATP and [Q-32 P]ATP (2 WCi/assay). To terminate the reaction, the phosphorylated product was separated from free isotope on ion-exchange phosphocellulose ¢lters (Whatman P-81). Papers were immersed immediately into ice-cold 75 mM H 3 PO 4 , washed (1U5 min, 3U20 min) and counted in a scintillation counter.
Measurement of MAP kinase activity
Lysates were prepared followed by immunoprecipitation of MAP kinase (p42 and p44) as described above. After three washes with immunoprecipitation bu¡er and two washes with kinase bu¡er (10 mM Tris^HCl, pH 7.2, 5 mM MgCl 2 , 1 mM MnCl 2 , 1 mM dithiothreitol, 0.1 mM sodium orthovanadate, 1 mM phenylmethylsulphonyl £uoride, 20 Wg/ml leupeptin, 20 Wg/ml aprotinin and 20 Wg/ml pepstatin), the immune complexes were incubated at 37³C for 10 min in kinase bu¡er (50 Wl/sample) containing myelin basic protein as an exogenous substrate for MAPK (20 Wg/assay), 25 WM ATP and [Q-32 P]ATP (2.5 WCi/ assay). To terminate the reaction, the phosphorylated product was separated from free isotope on ionexchange phosphocellulose ¢lters (Whatman P-81).
Papers were immersed immediately into ice-cold 75 mM H 3 PO 4 , washed (1U5 min, 3U20 min) and counted in a scintillation counter.
Cell transfection
Transfection with oligodeoxynucleotides (ODNs) using Lipofectin was performed according to the manufacturer's instructions. As in previous studies [41, 42] , ODNs were incubated with Lipofectin in DME for 15 min at room temperature. Plates of subcon£uent cells were washed to remove serum before addition of ODN^Lipofectin mixtures and incubation was performed for 12 h at 37³C. The ODN solution was removed, DME was added and the plates were placed in a metabolic incubator for an additional period of 36 h. Control treatments included DME or Lipofectin only. Dose^and timer esponse curves for Lipofectin and ODN were previously optimized (not shown).
The following ODN sequences with phosphorothioate linkages throughout the entire molecule were used: anti-c-Src, 5P-CACCACCATGGGGAG-CAGCA-3P (antisense against the 95^114 nucleotide sequence containing the AUG region from Gallus gallus c-Src mRNA); sense-c-Src, 5P-TGCTGCTCC-CCATGGTGGTG-3P.
Statistical analysis
Statistical signi¢cance of the data was evaluated using Student's t-test [43] and probability values below 0.05 (P 6 0.05) were considered signi¢cant. Results are expressed as means þ standard deviation (S.D.) from the indicated set of experiments.
Results and discussion
There is increasing evidence suggesting that Src tyrosine kinases have a pivotal role in the regulation of various cellular processes [44] . Members of this family are thought to be involved in signal transduction mechanisms linked to the MAPK cascade underlying the regulation of cell proliferation and di¡erentiation by agonists of receptor tyrosine kinases or heterotrimeric G protein-coupled receptors [45] . We have recently reported that the steroid hormone 1,25(OH) 2 D 3 stimulates, within 1^15 min, c-Src kinase activity in skeletal muscle cells by a mechanism that is sensitive to genistein and herbimycin and implies c-Src dephosphorylation [24] . To further explore hormone signal transduction in muscle cells, we initially determined whether Ca 2 is an upstream mediator of 1,25(OH) 2 D 3 -induced c-Src activation. As shown in Table 1 , using a c-Src speci¢c monoclonal antibody and enolase as c-Src substrate, we found, in agreement with previous observations [24] , that 5 min treatment with 1 nM 1,25(OH) 2 D 3 (hormone concentration which elicits a maximal response in muscle intracellular calcium levels [46, 47] ) caused a 12-fold increase in c-Src kinase activity in muscle cells. Membrane depolarization with high KCl (75 mM) elicited only a 1-fold activation of cSrc, an e¡ect that relies primarily on calcium in£ux from the outside. In muscle cells that have been loaded with the intracellular Ca 2 chelator BAPTA (5 WM), 90% inhibition of 1,25(OH) 2 D 3 -induced cSrc activity was observed. In avian skeletal muscle cells 1,25(OH) 2 D 3 stimulates c-Src kinase activity, at least in part, by altering the tyrosine phosphorylation state of the enzyme [24] and in rat colonocytes 1,25(OH) 2 D 3 activates Src by both phosphorylation-dependent and phosphorylation-independent mechanisms [25] . It is well established that phosphorylation of a conserved tyrosine residue (Y527) at the carboxy-terminal tail of the Src molecule negatively modulates its kinase activity by a mechanism which Skeletal muscle cells were incubated with 1,25(OH) 2 D 3 (1 nM) in the absence or presence of the intracellular Ca 2 chelator BAPTA (5 WM), KCl (75 mM) or vehicle ethanol ( 6 0.01%) for 5 min, and then lysed. Cell lysates were precipitated with anti-c-Src antibody and the tyrosine kinase activity in the precipitate was assayed using [Q-32 P]ATP and enolase as the exogenous substrate. The radioactive product was separated on phosphocellulose and its activity counted in a scintillation counter. Results are the average of three independent experiments performed in triplicate þ S.D. *P 6 0.001, **P 6 0.005. apparently implies intramolecular interaction of the carboxy-terminal phosphorylated tyrosine with the SH2 domain of Src [48, 49] . We then investigated the e¡ects of BAPTA and EGTA on hormone-induced changes in tyrosine phosphorylation of c-Src, by immunoprecipitation of c-Src followed by immunoblotting with anti-phosphotyrosine antibody. As shown in Fig. 1 , the hormone e¡ectively caused a decrease in the tyrosine phosphorylation status of c-Src (360% with respect to control), thus paralleling 1,25(OH) 2 D 3 stimulation of Src kinase-mediated enolase phosphorylation. In muscle cells loaded with the intracellular Ca 2 chelator BAPTA (5 WM), the reduction of c-Src dephosphorylation induced by the hormone was signi¢cantly attenuated (330% with respect to control), while pretreatment with EGTA (0.5 mM) abolished the e¡ects of 1,25(OH) 2 D 3 . These results suggest that both Ca 2 release from internal stores and Ca 2 in£ux from the external milieu contribute to c-Src activation by 1,25(OH) 2 D 3 in skeletal muscle cells. In agreement with this interpretation, we have previously shown that the hormone elicits a rapid IP 3 -mediated mobilization of Ca 2 from a thapsigargin-sensitive store [22] , and a sustained phase due to Ca 2 in£ux through VDCC and SOC channels [22, 23] . The less marked e¡ects of KCl than 1,25(OH) 2 D 3 to stimulate Src activity mentioned above (Table 1 ) may be explained by the fact that the former treatment only activates the VDCC Ca 2 pathway. Altogether, these results suggest that the mechanism by which the 1,25(OH) 2 D 3 -induced Ca 2 signal translates into an increase of c-Src may involve stimulation of a Ca 2 -dependent tyrosine phosphatase. In other cell types inhibition of calcium in£ux has been shown to prevent tyrosine phosphorylation of p60 c-Src kinase [45, 50] .
MAPK or extracellular signal-regulated kinase (ERK) consists of 42 and 44 kDa isoforms, and requires both tyrosine and threonine phosphorylation for activation [51, 52] . To evaluate whether the cytosolic tyrosine kinase c-Src is part of the 1,25(OH) 2 D 3 signalling mechanism involving MAPK in skeletal muscle cells [29] , we investigated the e¡ect of the cSrc family tyrosine kinase-selective inhibitor PP1 [53] on MAPK phosphorylation induced by the hormone. To that end, cells pretreated with 10 WM PP1, followed by exposure to 1 nM 1,25(OH) 2 D 3 for 1 min, were probed with anti-active MAP kinase antibody which recognizes the phosphorylated forms of both the 42 and 44 kDa species. As shown in Fig. 2 , under these conditions the e¡ects of the hormone on MAPK phosphorylation were abolished. Similar results were obtained when MAPK activity was measured, using myelin basic protein as a substrate (Table 2) . Antisense technology allows selective inhibition of the expression of one particular protein involved in signal transduction and to investigate how its knockout a¡ects a determined cell function [54, 55] . To answer the question to which extent complete abolition of 1,25(OH) 2 D 3 -stimulated MAPK by c-Src inhibition re£ects an absolute requirement of c-Src for the hormone-dependent MAPK activation, we blocked the expression of c-Src by transfecting cells with an antisense oligodeoxynucleotide against c-Src mRNA from G. gallus. As observed in Fig. 3 , in cells transfected with the c-Src antisense ODN the phosphorylation of MAP kinase induced by 1,25(OH) 2 D 3 was reduced up to 90% with respect to the control; however, the control c-Src sense ODN was not able to modify the magnitude of the hormone-dependent MAPK phosphorylation. Moreover, immunoblotting of cell lysates with anti-c-Src antibody proved the ability of the antisense ODN to suppress the targeted c-Src protein whereas no changes were detected in cells transfected with the sense ODN (data not given). Thus, the data from the above described set of experiments provide strong evidence indicating that activation of c-Src is Upon activation by various extracellular stimuli, MAP kinase translocates to the nucleus where it can activate (by phosphorylation) or induce the expression of transcription factors involved in DNA synthesis and cell division [45] . To investigate whether 1,25(OH) 2 D 3 operates through a similar mechanism, muscle cells were stimulated with the hormone (1 nM) for 3^15 min followed by isolation of nuclei. Immunoblot analysis with anti-active MAPK antibody showed that 1,25(OH) 2 D 3 signi¢-cantly increased the amounts of MAPK in the nuclear fraction between 3 and 10 min, with highest stimulation reached at 5 min (Fig. 4) . These results indicate that after hormone exposure MAPK is translocated to the nucleus in the active, phosphorylated form. Lower levels of MAPK than basal were detected after 15 min treatment with 1,25(OH) 2 D 3 , which may be tentatively attributed to hormone-dependent activation of tyrosine phosphatases.
It has been shown previously that the proliferative e¡ects of 1,25(OH) 2 D 3 in muscle cells [33] and HL-60 promyelocytic leukaemia cells [56] are accompanied by enhanced mRNA levels of the nuclear protooncoprotein c-myc known to induce the expression of genes involved in cell growth stimulation. Therefore, we then investigated the possibility that 1,25(OH) 2 D 3 upregulates the synthesis of the c-myc oncoprotein through the MAP kinase pathway. To that end, muscle cells were treated for 18 h with 1 nM 1,25(OH) 2 D 3 (concentration with leads to maximal activation of the MAPK cascade in these cells [31] ) in the presence or absence of PD98059 (10 WM), which inhibits MAPK activation by the dual MAPK kinase MEK. Cell lysates were immunoprecipitated followed by immunoblotting with a highly speci¢c anti-c-myc monoclonal antibody. As shown in Fig. 5 , the expression of c-myc, which appeared as a band of 65 kDa, was increased by 1,25(OH) 2 D 3 almost 1-fold (+90%; P 6 0.01) with respect to basal levels. However, when myoblasts were incubated with 1,25(OH) 2 D 3 in the presence of PD98059 the hormone response was markedly reduced (+23% with respect to PD98059 alone; P 6 0.05). Cells treated with PD98059 in the absence of metabolite showed a small increase (+18%) in c-myc levels which was not statistically signi¢cant. These results indicate that the MAPK cascade contributes to a great extent to 1,25(OH) 2 D 3 signalling pathways regulating c-myc synthesis.
There is evidence showing that c-myc function may be regulated by phosphorylation [57, 58] . The N-terminal domain of the c-myc protein has been reported to be critical for both transactivation and the biological function of the c-myc protein. The oncoprotein is phosphorylated at multiple sites in vivo, two of which have been identi¢ed near the amino terminus [59] . We have recently reported that 1,25(OH) 2 D 3 stimulates tyrosine phosphorylation of c-myc [31] . To evaluate if c-Src kinase is involved in 1,25(OH) 2 D 3 -induced c-myc phosphorylation, we pretreated muscle cells with the c-Src inhibitor PP1 (10 WM). Cell lysates were then immunoprecipitated with the anti-c-myc monoclonal antibody followed by Western blotting with anti-phosphotyrosine antibody. Fig. 6 shows that pretreatment of muscle cells with PP1 suppressed hormone-dependent tyrosine phosphorylation of c-myc. Moreover, in cells transfected with the c-Src antisense ODN the phosphorylation of c-myc induced by 1,25(OH) 2 D 3 was completely abolished (unpublished observations).
In conclusion, the results generated in the present study demonstrate that 1,25(OH) 2 D 3 stimulates cell proliferation signalling pathways related to MAP kinase and the oncoprotein c-myc in skeletal muscle and implicate c-Src kinase as mediator of this response. Activation of the Ca 2 messenger system in turn appears to play a primary role in triggering the increase in c-Src. As shown before, the transduction pathway events which occur between initiation of the 1,25(OH) 2 D 3 signal and the elevation of muscle intracellular Ca 2 include PKA-and PKC-dependent stimulation of VDCC, PLC-mediated Ca 2 mobilization from inner stores and activation of SOC channels via PKC and calmodulin [23, 60] . The new information here provided expands existing knowledge on the mechanism underlying modulation of muscle cellular growth by 1,25(OH) 2 D 3 [31^33]. 
